Colgate invests in gene therapy

11/7/2005 | NYTimes.com

Colgate-Palmolive and Introgen Therapeutics announced a partnership to pursue gene therapy mouthwashes and gels to treat and prevent oral cancers. Colgate-Palmolive is buying $20 million worth of Introgen's stock in a deal the companies hope will eventually develop prescription and over-the-counter products.

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Food & Beverage

Job Title Company Location
Lead Cook/Sous Chef
University of San Diego
San Diego, CA
Executive Chef - Shipboard
American Cruise Lines
Nationwide, SL_Nationwide
Executive Chef
The French Goat
Lewisburg, WV
CULINARY ARTS PROGRAM DIRECTOR AND INSTRUCTOR
Nashville State Community College
Nashville, TN
Executive Chef
Newport Harbor Corporation
Newport, RI